ConductScience.org, home

Paper6403103

Factors related to first dose hypotensive effect of captopril: prediction and treatment.

Hodsman GP and 5 others. Br Med J (Clin Res Ed), 1983. Cited by 150 papers, by iCite.

Cite this record

ConductScience Library. Factors related to first dose hypotensive effect of captopril: prediction and treatment. Papers, record 6403103. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6403103

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Factors related to first dose hypotensive effect of captopril: prediction and treatment.
PubMed
Journal
Br Med J (Clin Res Ed)
PubMed
Year
1983
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
150
iCite
Relative citation ratio, by iCite
7.63
iCite
Revised in PubMed
2019-05-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hodsman GPG P
2Isles CGC G
3Murray GDG D
4Usherwood TPT P
5Webb DJD J
6Robertson JIJ I

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CaptoprilMajor topic
HypertensionMajor topic
ProlineMajor topic
Aged
Angiotensin II
Creatinine
Dose-Response Relationship, Drug
Female
Humans
Hypotension
Male
Middle Aged
Renin
Sodium

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15452310Renin relationships in congestive cardiac failure, treated and untreated.Am Heart J1970https://conductscience.org/library/papers/5452310PubMed
24333501Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.Eur J Clin Invest1971https://conductscience.org/library/papers/4333501PubMed
397681Calibration and evaluation of a system of total body in vivo activation analysis using 14 MeV neutrons.Phys Med Biol1978https://conductscience.org/library/papers/97681PubMed
4214819Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients.Prog Cardiovasc Dis1978https://conductscience.org/library/papers/214819PubMed
56987010A microassay for active and total renin concentration in human plasma based on antibody trapping.Clin Chim Acta1980https://conductscience.org/library/papers/6987010PubMed
66156900Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor.Hypertension1980https://conductscience.org/library/papers/6156900PubMed
77000102
Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Br Heart J1980https://conductscience.org/library/papers/7000102PubMed
86253115The effect of captopril on blood pressure and angiotensins I, II and III in sodium-depleted dogs: problems associated with the measurement of angiotensin II after inhibition of converting enzyme.Clin Sci (Lond)1980https://conductscience.org/library/papers/6253115PubMed
97002436Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect.Clin Sci (Lond)1980https://conductscience.org/library/papers/7002436PubMed
107004680Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients.Clin Exp Pharmacol Physiol1980https://conductscience.org/library/papers/7004680PubMed
117007685Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension.Jpn Heart J1980https://conductscience.org/library/papers/7007685PubMed
127030291Use of captopril in the diagnosis of renal hypertension.Aust N Z J Med1981https://conductscience.org/library/papers/7030291PubMed
137037024Hyponatraemia as a marker for high renin heart failure.Br Heart J1982https://conductscience.org/library/papers/7037024PubMed
146802290Captopril in renovascular hypertension: long-term use in predicting surgical outcome.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6802290PubMed
157041586Clinical experience with captopril in the treatment of severe drug-resistant hypertension.Am J Cardiol1982https://conductscience.org/library/papers/7041586PubMed
166809465Malignant hypertension and oral contraceptives: four cases, with two due to the 30 micrograms oestrogen pill.Eur Heart J1982https://conductscience.org/library/papers/6809465PubMed
1714306581PLASMA RENIN CONCENTRATION IN HUMAN HYPERTENSION. 1. RELATIONSHIP BETWEEN RENIN, SODIUM, AND POTASSIUM.Br Med J1965https://conductscience.org/library/papers/14306581PubMed

Download CSV of references

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.

PMIDTitleJournalYearIn PapersSource
37446639Chemical Synthesis, Safety and Efficacy of Antihypertensive Candidate Drug 221s (2,9).Molecules2023https://conductscience.org/library/papers/37446639PubMed
29375230Prolonged First-Dose Hypotension Induced by Sacubitril/Valsartan.Acta Cardiol Sin2018https://conductscience.org/library/papers/29375230PubMed
26976916Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.Circulation2016https://conductscience.org/library/papers/26976916PubMed
23266540Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure.Hypertension2013https://conductscience.org/library/papers/23266540PubMed
15663349Postural blood pressure changes and orthostatic hypotension in the elderly patient: impact of antihypertensive medications.Drugs Aging2005https://conductscience.org/library/papers/15663349PubMed
9723827Start of therapy with the angiotensin II antagonist losartan after immediate switch from pretreatment with an ACE inhibitor.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9723827PubMed
9663811Determinants of the blood pressure response to the first dose of ACE inhibitor in mild to moderate congestive heart failure.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9663811PubMed
9114905The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril.Br J Clin Pharmacol1993https://conductscience.org/library/papers/9114905PubMed
8894524Optimal dosage of ACE inhibitors in older patients.Drugs Aging1996https://conductscience.org/library/papers/8894524PubMed
8573991ACE inhibitors. Differential use in elderly patients with hypertension.Drugs Aging1995https://conductscience.org/library/papers/8573991PubMed
8471406Haemodynamic and hormonal responses to oral enalapril in salt depleted normotensive man.Br J Clin Pharmacol1993https://conductscience.org/library/papers/8471406PubMed
8460511Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?West J Med1993https://conductscience.org/library/papers/8460511PubMed
8261712Enalapril clinical pharmacokinetics and pharmacokinetic-pharmacodynamic relationships. An overview.Clin Pharmacokinet1993https://conductscience.org/library/papers/8261712PubMed
7946798Role of ACE inhibitors in uncomplicated essential hypertension.Br Heart J1994https://conductscience.org/library/papers/7946798PubMed
7833591Changes in the renin-angiotensin-aldosterone axis in later life.Drugs Aging1994https://conductscience.org/library/papers/7833591PubMed
7833222Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.Br J Clin Pharmacol1994https://conductscience.org/library/papers/7833222PubMed
7833218Clinical pharmacology, physiology and pathophysiology of superficial veins--2.Br J Clin Pharmacol1994https://conductscience.org/library/papers/7833218PubMed
7691497Drug therapy of renovascular hypertension.Drugs1993https://conductscience.org/library/papers/7691497PubMed
6412854Captopril: five years on.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6412854PubMed
6315126Enalapril in the treatment of hypertension with renal artery stenosis.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6315126PubMed

See all 46 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGT183PubTator's text mininghttps://conductscience.org/library/genes/183NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6403103

GET https://conductscience.org/api/papers/v1/6403103/cited_by?page=2